Skip to content
Connect AISign inSign up free
CVE-2026-680679.8CriticalCWE-1390

CVE-2026-68067: Mira Hormone Monitor, Mira Android App Weak Authentication

Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Firmware

Vendor fix available · Affected: Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware · Exploitation: not established

ExploitationNot established

Not in CISA KEV as of catalogue 2026.11.13 (13 Nov)

  1. In CISA KEV: not seen
  2. Exploited (reported): not seen
  3. Scanning observed: not seen
  4. Proof of concept public: not seen
  5. Not establishedNothing in the sources we check
0.5%probability of exploitation in the next 30 days
44th percentile
050100

Higher than 44% of scored CVEs

9.8CriticalCVSS 4.0
LowCrit.

DescriptionNVD

The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas
Exploitation
Unlikely (under 1%). EPSS under 1%, or no score yet.
CISA KEV
Not listed
Public check
No public nuclei template
Published
August 2026

Coverage1 article · 1 outlet

First in our coverage: SecurityOnline, 14 Aug.

New articles also arrive in the RSS feed.

References